No Data
Shandong Lukang Pharmaceutical Gets Approval for Anticoagulant for Knee, Hip Replacement Surgery
Shandong Lukang Pharmaceutical (600789.SH) has obtained the pharmaceutical registration certificate and approval notice for the listing application of chemical raw materials.
Shandong Lukang Pharmaceutical (600789.SH) announced that recently, the company received a document from the National Medical Products Administration regarding Apixaban...
China Aprpoves Lukang Pharma Unit's Supplementary Drug Application for Heart Injection
Express News | Shandong Lukang Pharmaceutical: Received the Notice of Approval for Drug Clinical Trials.
Express News | Shandong Lukang Pharmaceutical: Clinical trial approval for injection use of CIGB-814 granted.
Investors are paying attention to the progress of FT606. shandong lukang pharmaceutical did not directly respond to the production time | Live coverage of the earnings conference.
①The progress of the company's new synthetic biotechnology material product FT606 has attracted much attention. ②The pharmaceutical industry was in the traditional off-season in the third quarter, leading to a decline in the company's Q3 earnings. ③During the earnings conference, a questioner who claimed to be an investor expressed dissatisfaction with the lack of interaction.
No Data
No Data